Rebecca B. Price, PhD, Co-Director
Dr. Price is an assistant professor in the Department of Psychiatry at the University of Pittsburgh. She completed undergraduate studies in cognitive science at Stanford University and a PhD in Clinical Psychology at Rutgers University. Her research interests center on the role of neurocognitive factors in the etiology, course, and treatment of depression, anxiety, and suicidality. She is particularly interested in the intersection of clinical and neurocognitive research--for example, 1) translating basic cognitive and affective neuroscience findings into novel brain-based behavioral and pharmacological interventions and 2) identifying individual differences in neural and cognitive function that predict response to specific treatments. She has recently focused on attentional bias towards threat as a neurocognitive mechanism contributing to anxiety. She is currently completing an NIMH-funded K23 Career Development Award that focuses on neurocognitive markers of attentional bias and the relationship between these markers and response to a computer-based intervention (attention bias modification). Other recent work includes studies of the effects of ketamine, a novel pharmacological intervention that exhibits rapid antidepressant effects, on suicidal cognition (assessed through traditional as well as performance-based/reaction time measures); and studies of the effectiveness, moderators, and mechanisms of neurocognitive and cognitive-behavioral interventions for depression and anxiety.
Click here to view publication list
Jay Fournier, PhD, Co-Director
Dr. Fournier is an assistant professor in the Department of Psychiatry at the University of Pittsburgh School of Medicine. He earned his PhD in Clinical Psychology from the University of Pennsylvania and completed his clinical psychology internship at Western Psychiatric Institute and Clinic. Dr. Fournier’s research focuses on identifying patient characteristics that are associated with differential response to various forms of treatment for depression, including placebo, antidepressant medications, and psychotherapy. In addition, his work investigates the mechanisms through which those characteristics either facilitate or inhibit response to relevant treatments. As such, Dr. Fournier’s research bridges work in clinical interventions, personality and individual differences, and affective neuroscience. With support from a K23 Career Development Award, funded by NIMH, Dr. Fournier is currently examining whether neural markers of individual difference in emotion regulation in depressed adults can help to explain recently observed effects of personality traits on response to treatments. Additional work in Dr. Fournier’s lab includes an examination of the effects of baseline symptom severity on response to treatments for depression, the ability of treatments to alter functional outcomes for depressed individuals, and the role of subthreshold manic symptoms in the functioning of treatment-relevant emotion processing and emotion regulation neural regions among depressed outpatients.
Logan Cummings, Research Specialist
Logan Cummings is a research specialist at the University of Pittsburgh Medical Center. He received his undergraduate degree in psychology from The University of Tampa. Logan is extremely interested in translational research. He currently assists Drs. Price and Fournier with their neurocognitive studies of depression and anxiety disorders.
|Selection||File type icon||File name||Description||Size||Revision||Time||User|